Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
ACEST SIMBOL NU MAI ESTE ACTIV

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionAperio Group, LLC
Latest Disclosed Ownership49,436 shares
Latest Disclosed Value $ 1,141,000
Aperio Group, LLC reports 1.20% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 49,436 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $1,141,477 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 48,851 shares of Amicus Therapeutics, Inc.. This represents a change in shares of 1.20% during the quarter. The current value of the position is $716,328 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 49,436 585 1.20 1,141 65.36 0.0034
2020-11-06 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 48,851 2,187 4.69 690 -1.99 0.0023
2020-08-13 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 46,664 5,138 12.37 704 83.33 0.0026
2020-05-05 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 41,526 -11,221 -21.27 384 -25.29 0.0017
2020-02-13 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 52,747 26,596 101.70 514 144.76 0.0018
2019-11-06 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 26,151 389 1.51 210 -34.78 0.0008
2019-07-30 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 25,762 4,026 18.52 322 8.78 0.0013
2019-05-13 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 21,736 1,525 7.55 296 52.58 0.0013
2019-05-06 2018-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 20,211 3,534 21.19 194 -3.96 0.0010
2019-02-14 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 20,211 3,534 194
2019-05-06 2018-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 16,677 1,323 8.62 202 -15.83 0.0009
2018-10-17 2018-09-30 13F AMICUS THERAPEUTICS I COMMON 03152W109 16,677 1,323 202
2019-05-06 2018-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 15,354 -396 -2.51 240 1.27 0.0011
2018-07-30 2018-06-30 13F AMICUS THERAPEUTICS I COMMON 03152W109 15,354 -396 240
2019-05-01 2018-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 15,750 77 0.49 237 4.87 0.0012
2018-05-08 2018-03-31 13F AMICUS THERAPEUTICS I COMMON 03152W109 15,750 77 237
2019-05-01 2017-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 15,673 347 2.26 226 -2.16 0.0012
2018-02-02 2017-12-31 13F AMICUS THERAPEUTICS I COMMON 03152W109 15,673 347 226
2019-05-01 2017-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 15,326 1,340 9.58 231 63.83 0.0013
2017-10-25 2017-09-30 13F AMICUS THERAPEUTICS I COMMON 03152W109 15,326 1,340 231
2019-04-22 2017-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 13,986 1,663 13.50 141 60.23 0.0009
2017-07-18 2017-06-30 13F AMICUS THERAPEUTICS I COMMON 03152W109 13,986 1,663 141
2019-04-22 2017-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 12,323 0 88 0.0006
2017-05-05 2017-03-31 13F AMICUS THERAPEUTICS I COMMON 03152W109 12,323 88
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.